Intelligencer
The Cut
Vulture
The Strategist
Curbed
Grub Street
Magazine
Subscribe to the Magazine
Give a Gift Subscription
Buy Back Issues
Current Issue Contents
New York
Shop
Subscribe
Sign In
Account
Profile
Sign Out
Subscribe
Give A
Gift
Displaying all articles tagged:
Drug Prices
the republican party
July 12, 2019
Why the GOP Might Learn to Love Putting Price Controls on Drugs
Conservatives’ traditional defense of America’s high drug prices is completely at odds with Trump’s “America first” ideology.
By
Eric Levitz
trade
Mar. 29, 2019
Trump’s NAFTA 2.0 Puts Big Pharma First, America Second
Trump says lowering pharmaceutical prices is a priority. But his trade deal would bar Congress from curtailing patent monopolies on biologic drugs.
By
Eric Levitz
2018 midterms
Oct. 26, 2018
Drug Costs Are Too High, But Trump’s Proposal Was Primarily About the Midterms
Trump’s attack on “global freeloaders” sounds like nationalist rhetoric meant to counter the GOP’s weaknesses on health care.
By
Sarah Jones
Feb. 28, 2017
The Socialist Takeover of the Democratic Party Is Proceeding Nicely
Centrist Democrats used to distance themselves from the left ahead of their presidential runs. Now, Booker and Cuomo are doing the opposite.
By
Eric Levitz
Feb. 3, 2017
Company Raises Price of Opioid-Overdose Antidote by 500 Percent, to $4,500
Earlier this week, President Trump backed off his pledge to bargain with drug companies over their prices.
By
Eric Levitz
Jan. 31, 2017
Trump Meets Big-Pharma CEOs, Then Seems to Flip-flop on Negotiating Drug Prices
On the campaign trail he mocked the lobbyists. Today he sounded like one.
By
Ed Kilgore
Jan. 11, 2017
Trump Tanks Pharma Stocks With Sudden Threat to Fight High Drug Prices
In his first press conference, he revived a nearly forgotten plan to authorize government negotiations on pharmaceutical prices.
By
Ed Kilgore
Dec. 21, 2016
The Opioid Epidemic Is a Symptom of Toxic Greed
Our system of financing drug research gave the makers of OxyContin a multibillion-dollar incentive to ignore the risks their drug posed.
By
Eric Levitz
Oct. 17, 2016
Investors Seem to Think Hillary Clinton Really Will Take On Big Pharma
As Clinton’s electoral odds rise, the value of health-care stocks goes down.
By
Eric Levitz
Sept. 2, 2016
Clinton Reveals New Plan to Help Americans Score Cheaper Drugs
As EpiPens become luxury goods, the Democratic nominee unveils a plan for reining in drug prices.
By
Eric Levitz
Aug. 26, 2016
CEO of Price-Gouging Drug Company Could Have Picked a Better Binder to Pose With
“Compensation planning.”
By
Eric Levitz